Habil Khorakiwala

Indian pharmaceutical company Wockhardt has stated that it has secured a deal with the government for a new COVID vaccine, details of which will be announced in next two-weeks. Wockhardt chairman Habil Khorakiwala informed that the vaccine's production will start in October with a capacity of 500 million doses per year. However, name and price of the vaccine have not been disclosed yet.